26 September 2020
Wireless Health Market Forecast 2020-2030: Forecasts and Analysis By Technology, By Component Type, By Application and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Wireless Health sector analysis.
According to the report published by Visiongain, the Wireless Health market was valued at approximately USD xx billion in 2019 and is expected to grow at a CAGR of around xx% between 2020 and 2030.
This report presents a wireless monitoring system based on mobile devices which can provide online information in real time regarding a patient's physiological conditions. In the last decade, scientists have received considerable interest from health monitoring programs. The overall objective was to establish a robust patient monitoring system so that clinicians would track their clients, either in clinic or in regular day-to-day practice. Furthermore, the system can send alarming messages by text messages or email reports on the critical health data of the patient. The health professionals can provide necessary medical advice through the use of the information contained in the text or e-mail message. The system consists mainly of sensors, data acquisition units, microcontrollers, and software (LabVIEW, for example). Our machine tracks, records and stores patient temperature, pulse speed, muscles, blood pressure, amount of blood glucose and ECG information. The proposed system was tested in the field to ensure reliability and accuracy.
Wireless Health Market is witnessing Growth due to factors such as
In recent years, mobile telephone technology has progressed. Including traditional speech information transmission, most groundbreaking technologies for cell phones have been implemented. In the recent past, a number of applications including business transactions have been identified for short message service (SMS) originally developed for the sending of service provider’s status data. A prototype of a wireless health monitoring system is developed in this project that can send SMS related to the patient's health situation. The project can be divided into three phases of acquisition, processing of data and communication. A data acquisition phase is made up of the temperature and pulse rate monitoring sensors. The sensor outputs are digitally converted and read by a Basic Stamp microcontroller which is processed and sent to Visual BasicTM data processing software through the serial port.
In Visual Basic various GUI modes are developed to support data processing, for example, patient information. Important values can be applied to measured data, which exceeds the values set by the Visual Basic for sendering SMS to predefined mobile numbers in the contact system. When faults or thresholds are detected, the surveillance system transmits information automatically to the physician's mobile telephone via a GSM / SMS gateway via an SMS message Different design options have been considered and the best is selected for each stage of the project. As a prototype, the project succeeded in sending patient information SMS to the physicians. Given that only a prototype was intended for this project, accuracy of sensors and other data acquisition features were affected by selecting the available sensor or simulating it instead of using biomedical sensors due to cost and availability factors.
For an effective PMS it is of prime importance that a patient has to register and notify the vital signs in real-time. Modern PMS systems should acquire, record, display and transmit the physiological data from the patient body to a remote location at all times by encapsulating the advantages of modern bioinstrumentation, computers and telecoms technologies. PMS must also be combined with an alarm system for more reliable, prompt and emergency medical care. The PMS should not only monitor and analyze the critical patient information, it should send an alarming signal when the monitored data goes away. to alert both the patient and providers of health services outside their normal ranges. The PMS must therefore be associated with an active database system. The majority of PMSs proposed are centralized in such a way that all patient data is stored on one single server. The database can be linked via TCP / IP protocol to an open communication network with the appropriate firmware and code. A patient can therefore be monitored remotely. In this respect, existing and broad mobile telephone networks can help.
Shift in Trends
Cell networks have lately been seen as important to solving future challenges to the field of health. The digital healthcare system (i.e. m Health) is a developed innovation with the global market saturation of mobile phones. By using the mobile phone, people who live in remote locations without much access to other types of communications can be provided with medical services. Even a simple mobile telephone can now become an effective medical device. Text messages and phone calls can provide the patient in a remote location in real-time and critical information quickly. While clinicians in remote regions will cut back and forth needless trips in far-reaching medical facilities. Mobile devices are, however, now "intelligent" to do more than just provide medical information and advice. With support for high-speed data services, the smartphone has revolutionized the medical system by acting as a powerful physician to monitor the health of patients.
Cardiac illness and diabetic systems are now widely used to monitor and control heart disease. There are now estimated 95,000 medical applications available, which have been downloaded to their smartphones by over 200 million people. By 2015, 500 million people are scheduled to use medical applications. The most popular technological evolution of physicians since the invention of stethoscopes are also calculated for smartphones and tablets. Smartphones in the United States are used by doctors not only for accessing medical references and training material and professional journals but also for patient monitoring, image management and bedside care. Smartphones allow patients to play a more active role in improved health, for example the management of appointments, updates of prescriptions and access to me. Smartphones therefore have a highest level of healthcare.
Regional Market Analysis
With a share of more than xx per cent, North America became the largest market in 2019. The increasing burden of illness and increased expenditure in health care, which requires cost-cutting measures, are key factors contributing to its share. In addition, improved IT infrastructure for health care, increased IT services adoption and awareness of wireless technology among the population are a few factors contributing to market growth. Increasing population dependent on fitness equipment has a significant impact on the market.
In North America, health expenditure is projected to be increased by about 4.6% annually between 2015 and 2019. The growth in wireless health may be attributable to paid trends moving towards value-based payment models and the development of platforms such as PHM, care management and point-of-care solutions. In addition, regional eHealth development initiatives and clinical interoperability are factors that enhance growth in the market.
The highest CAGR of xx per cent will occur in Asia Pacific. The region's rapid growth has led to a better healthcare infrastructure, greater Internet penetration and a growing awareness of wireless technologies. More important market opportunities are expected to be present with an increase in the geriatric population and a growing burden of chronic disease. Initiatives to promote eHealth and interoperability are undertaken by governments of several countries. Various legislation and standards to secure patient information are also introduced to protect the interests of the patient.
Competition in the market
Cerner Corporation, for instance, announced in February 2016 a collaborative partnership with xG Solutions, Inc. that would provide Cerner company access to the Health Intent platform for management of PHM outcomes and risks. The clinical content of xG, on the other hand, was intended to improve Cerner's Health Care and Health Analytics Care Management solutions. This will lead to individualized patient assessments of different circumstances that can be integrated in the workflow and allow patient-specific medical plan to be automated for customized treatment.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.
26 November 2020
Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.
25 November 2020
Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth
24 November 2020
Increasing prevalence of cardiovascular diseases is increasing demand of biological imaging reagents for the diagnosis and treatment of cardiovascular diseases due to this reason increasing prevalence of cardiovascular diseases is acting as a driver for biological imaging reagent market.